MedTrace Logo

Medical Nutrition Formulations Enriched With Postbiotics for the Management of Gastrointestinal Disorders

NCT06738420 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-10-07

No results posted yet for this study

Summary

Efficacy and tolerability of ABB i5 prebiotic and ABB C22 postbiotics for the management of constipation and gastrointestinal well-being: a pilot trial

Conditions

  • Diarrhoea of Diverse Aetiology Requiring Oral Rehydration Therapy
  • Diarrhoea and Gastrointestinal Symptoms Secondary to Enteral Nutrition

Interventions

DIETARY_SUPPLEMENT

ABB S3

Postbiotic ABB S3 for suspension into Nutritional supplementation with Medical Nutrition Formula for the management of gastrointestinal symptoms secondary to enteral nutrition

DIETARY_SUPPLEMENT

ABB C22

Oral Rehydration Solution containing postbiotics ABB C22 for the management of diarrhoea signs of dehydration

DIETARY_SUPPLEMENT

Placebo

Placebo for suspension into Nutritional supplementation with Medical Nutrition Formula for the management of gastrointestinal symptoms secondary to enteral nutrition

DIETARY_SUPPLEMENT

Placebo

Oral Rehydration Solution containing placebo for the management of diarrhoea signs of dehydration

Sponsors & Collaborators

  • Colisée Barcelona Isabel Roig

    collaborator UNKNOWN

  • Grupo Colisée

    collaborator UNKNOWN

  • AB Biotek

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-27
Primary Completion
2024-03-06
Completion
2024-04-04

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06738420 on ClinicalTrials.gov